WEBVTT - The Future of Clinical Trials

0:00:00.160 --> 0:00:07.200
<v Speaker 1>Brought to you by Toyota. Let's go places. Welcome to

0:00:07.400 --> 0:00:15.200
<v Speaker 1>Forward Thinking. Hey there, and welcome to Forward Thinking, the

0:00:15.320 --> 0:00:18.160
<v Speaker 1>podcast that looks at the future and said soon turned

0:00:18.160 --> 0:00:21.760
<v Speaker 1>out had a heart of glass. I'm Jonathan, I'm Lauren Focan,

0:00:21.920 --> 0:00:25.280
<v Speaker 1>and I'm Joe McCormick. So you know, I I pitched

0:00:25.320 --> 0:00:29.520
<v Speaker 1>this idea for this episode. Um and uh, it's all

0:00:29.560 --> 0:00:34.199
<v Speaker 1>about organs on chips, and you guys really when nuts

0:00:34.240 --> 0:00:37.760
<v Speaker 1>with the whole research and it was only about five

0:00:37.760 --> 0:00:40.120
<v Speaker 1>hours into it that we suddenly realized that it's it's

0:00:40.360 --> 0:00:44.000
<v Speaker 1>it's not about snack food. No, it is not about

0:00:44.240 --> 0:00:47.199
<v Speaker 1>putting like sheep organs on French fries and what they

0:00:47.200 --> 0:00:50.240
<v Speaker 1>would call that in England. Well, I'm a really big fan.

0:00:50.320 --> 0:00:52.960
<v Speaker 1>Actually if the entire genre of kind of you know,

0:00:53.360 --> 0:00:56.720
<v Speaker 1>the awful and the chips are delicious. Ye, you're you're

0:00:56.720 --> 0:00:58.760
<v Speaker 1>talking awful as an o F F a L right,

0:00:58.800 --> 0:01:03.600
<v Speaker 1>not not a WF you well were We were really

0:01:03.600 --> 0:01:06.480
<v Speaker 1>really we're really interested in in covering that in the

0:01:06.520 --> 0:01:09.319
<v Speaker 1>future of it. But as it turns out, the the

0:01:09.400 --> 0:01:14.240
<v Speaker 1>what organs on chips actually are is pretty darn fascinating

0:01:14.280 --> 0:01:19.119
<v Speaker 1>and it's all about transforming how clinical tests would be

0:01:19.200 --> 0:01:21.760
<v Speaker 1>carried out. But in order for us to talk about transforming,

0:01:22.120 --> 0:01:23.760
<v Speaker 1>we kind of have to lay some groundwork, right, We

0:01:23.800 --> 0:01:27.559
<v Speaker 1>need to talk about how clinical trials happen. How, How

0:01:27.800 --> 0:01:32.679
<v Speaker 1>do how does the medical profession evaluate and regulate things

0:01:32.720 --> 0:01:36.920
<v Speaker 1>like drugs? For example? Yeah, because you can't just make

0:01:36.959 --> 0:01:39.120
<v Speaker 1>a drug and put it in a bottle and then

0:01:39.160 --> 0:01:41.760
<v Speaker 1>go sell it to anybody. Can Well you can, but

0:01:42.040 --> 0:01:46.000
<v Speaker 1>legally you'd be culpable for that. Anything that you claim

0:01:46.080 --> 0:01:49.800
<v Speaker 1>has a pharmacological effect, you would then be probably brought

0:01:49.920 --> 0:01:53.000
<v Speaker 1>under the uh the attention of the Food and Drug

0:01:53.040 --> 0:01:57.120
<v Speaker 1>Administration here in the United States or whatever other regulatory

0:01:57.160 --> 0:01:59.640
<v Speaker 1>body you have, and whatever other countries. What if I

0:01:59.680 --> 0:02:02.600
<v Speaker 1>call it a natural remedy, So now then you get

0:02:02.640 --> 0:02:06.800
<v Speaker 1>a little more leeway in some countries. But that's that's

0:02:06.840 --> 0:02:09.760
<v Speaker 1>a different conversation. Okay, No, Let's let's look at actual

0:02:09.880 --> 0:02:14.080
<v Speaker 1>mainstream pharmaceuticals. Let's say that I am a researcher and

0:02:14.120 --> 0:02:17.519
<v Speaker 1>I've come up with a new compound that I think

0:02:17.560 --> 0:02:22.600
<v Speaker 1>will help cure some disease. What happens before I can

0:02:22.639 --> 0:02:25.640
<v Speaker 1>actually give that to people to help them? How? What

0:02:25.680 --> 0:02:27.600
<v Speaker 1>are all the processes I have to go to find

0:02:27.600 --> 0:02:29.720
<v Speaker 1>out whether or not it works, whether or not it's safe,

0:02:29.760 --> 0:02:33.880
<v Speaker 1>to get all the government approvals what happens. Luckily we

0:02:33.919 --> 0:02:37.800
<v Speaker 1>have Lauren here, who is our our medical guru. So, Lauren,

0:02:38.080 --> 0:02:41.240
<v Speaker 1>do you feel comfortable tackling some of this, Yeah, sure, totally.

0:02:41.760 --> 0:02:43.920
<v Speaker 1>First of all, it's going to depend on what country

0:02:43.960 --> 0:02:46.320
<v Speaker 1>you're in, because regulations are going to be different under

0:02:46.360 --> 0:02:50.480
<v Speaker 1>any any different government obviously, but the pre clinical and

0:02:50.520 --> 0:02:54.200
<v Speaker 1>clinical trial procedures are similar around the world. We're going

0:02:54.280 --> 0:02:57.800
<v Speaker 1>to talk specifically about the US ones right now, so

0:02:57.880 --> 0:03:01.920
<v Speaker 1>let us talk about those two phases, the preclinical and

0:03:02.160 --> 0:03:05.320
<v Speaker 1>the clinical. During the pre clinical first, Joe, if you

0:03:05.360 --> 0:03:09.560
<v Speaker 1>have made a compound, that's that's heads above many other

0:03:09.639 --> 0:03:12.840
<v Speaker 1>people in the research industry right this very moment. It

0:03:12.919 --> 0:03:17.000
<v Speaker 1>takes a lot of doing to actually create a compound

0:03:17.080 --> 0:03:19.840
<v Speaker 1>that you think is going to solve a particular problem.

0:03:19.880 --> 0:03:23.079
<v Speaker 1>You know, you might be trying to inhibit or amplify

0:03:23.200 --> 0:03:27.040
<v Speaker 1>a particular enzyme that does something or isn't doing something correctly.

0:03:27.680 --> 0:03:31.240
<v Speaker 1>And so once once you've got a bunch of computer

0:03:31.400 --> 0:03:35.520
<v Speaker 1>modeling and in vitro, that's that's lab dish testing done,

0:03:35.960 --> 0:03:40.400
<v Speaker 1>then you can move forward to the next part. Okay,

0:03:40.440 --> 0:03:43.320
<v Speaker 1>so I've done initial testing, I've I've got a compound,

0:03:43.360 --> 0:03:46.120
<v Speaker 1>I've settled on what do I need to do next? Next,

0:03:46.280 --> 0:03:49.360
<v Speaker 1>you need to test it in living animals. And I

0:03:49.400 --> 0:03:52.480
<v Speaker 1>know that that this is a very sensitive and squeamish

0:03:52.480 --> 0:03:55.600
<v Speaker 1>topic for a lot of people. And I absolutely understand that.

0:03:55.680 --> 0:03:59.120
<v Speaker 1>I don't think that anyone medical researchers included are twisting

0:03:59.160 --> 0:04:01.080
<v Speaker 1>their mustaches go and like, yes, we are going to

0:04:01.160 --> 0:04:03.880
<v Speaker 1>hurt these rats today, at least I hope not that

0:04:03.880 --> 0:04:06.720
<v Speaker 1>would be I'm very fond of rats personally. But it's

0:04:06.800 --> 0:04:08.960
<v Speaker 1>incredibly important and we'll get into that a little bit

0:04:09.040 --> 0:04:12.400
<v Speaker 1>later on. Um, but let us suffice it to say

0:04:12.440 --> 0:04:15.160
<v Speaker 1>at the current moment that different animals are used for

0:04:15.200 --> 0:04:19.560
<v Speaker 1>their similarities to two different human systems. For example, pigs

0:04:19.560 --> 0:04:23.880
<v Speaker 1>cardiovascular systems are surprisingly similar to humans. Uh though, rats

0:04:23.920 --> 0:04:26.600
<v Speaker 1>are the go to for lots of drug testing, especially

0:04:26.640 --> 0:04:29.400
<v Speaker 1>at these early stages that we're talking about, right, So

0:04:29.640 --> 0:04:32.600
<v Speaker 1>that's probably because lots of mammals are pretty much all

0:04:32.760 --> 0:04:35.280
<v Speaker 1>mammals share a lot of things in common, even though

0:04:35.279 --> 0:04:38.760
<v Speaker 1>they don't necessarily share everything. Uh yeah, we also don't

0:04:38.800 --> 0:04:41.520
<v Speaker 1>share many, many, many things, and that's part of why

0:04:41.560 --> 0:04:44.720
<v Speaker 1>this whole organ onic chip discussion has been rearing up.

0:04:45.080 --> 0:04:48.080
<v Speaker 1>But uh, the things that you're looking for with animal

0:04:48.120 --> 0:04:51.159
<v Speaker 1>testing include like how much of a compound will be

0:04:51.200 --> 0:04:53.479
<v Speaker 1>absorbed by the body, or how the body will break

0:04:53.520 --> 0:04:57.839
<v Speaker 1>it down into into the metabolites, or the toxicity of

0:04:57.839 --> 0:05:00.960
<v Speaker 1>the compound and its metabolites at levels that are likely

0:05:01.000 --> 0:05:03.320
<v Speaker 1>to be used for the intended purpose of the drug,

0:05:03.800 --> 0:05:07.080
<v Speaker 1>or how quickly the compound and its metabolites will be

0:05:07.160 --> 0:05:09.880
<v Speaker 1>excreted from the body, all of these being of course,

0:05:09.960 --> 0:05:12.760
<v Speaker 1>very important to figuring out how a drug works. Right. So,

0:05:12.880 --> 0:05:15.760
<v Speaker 1>in other words, if I take a drug and it

0:05:15.760 --> 0:05:19.960
<v Speaker 1>turns out that only a tiny percentage of whatever that

0:05:20.200 --> 0:05:24.600
<v Speaker 1>substance is actually gets absorbed by my body, then you

0:05:24.640 --> 0:05:27.720
<v Speaker 1>would you could draw the conclusion that that wasn't a

0:05:27.839 --> 0:05:32.400
<v Speaker 1>very efficient use of that particular dose of drug. You

0:05:32.400 --> 0:05:35.200
<v Speaker 1>could say, it's not that the drug is necessarily ineffective.

0:05:35.480 --> 0:05:37.760
<v Speaker 1>It may be that you need to make up more

0:05:37.920 --> 0:05:42.240
<v Speaker 1>of that that dose with other inactive elements to make

0:05:42.320 --> 0:05:46.160
<v Speaker 1>up whatever that particular delivery system is. Oh sure, maybe

0:05:46.200 --> 0:05:48.440
<v Speaker 1>you need to tweak the compound itself, or maybe you

0:05:48.480 --> 0:05:50.919
<v Speaker 1>need to change the delivery method. Maybe we're injecting it

0:05:50.960 --> 0:05:53.039
<v Speaker 1>but it needs to be taken orally. There's all kinds

0:05:53.080 --> 0:05:57.760
<v Speaker 1>of I mean numerous multitudes of variables that can go

0:05:57.839 --> 0:06:00.560
<v Speaker 1>into any stage of this process and it testing and

0:06:00.560 --> 0:06:04.400
<v Speaker 1>it's safety, uh and and it's so complicated that traditionally

0:06:04.480 --> 0:06:07.920
<v Speaker 1>computer modeling has never been good enough to substitute for

0:06:08.240 --> 0:06:11.839
<v Speaker 1>actual physical animal testing. I mean, just because our bodies

0:06:11.880 --> 0:06:14.800
<v Speaker 1>are so ridiculously complex and our systems are tied to

0:06:14.839 --> 0:06:18.120
<v Speaker 1>each other in ways that we really don't understand yet,

0:06:18.440 --> 0:06:21.600
<v Speaker 1>which sounds ridiculous being that we live in the incredible future.

0:06:21.720 --> 0:06:23.920
<v Speaker 1>But we've said many times on this show that the

0:06:24.000 --> 0:06:26.280
<v Speaker 1>human body is kind of one of those science things

0:06:26.279 --> 0:06:28.560
<v Speaker 1>that we just don't don't have worked out yet. Well, yeah,

0:06:28.560 --> 0:06:30.520
<v Speaker 1>as it turns out that if you want to learn

0:06:30.600 --> 0:06:35.240
<v Speaker 1>a lot about the human body, there's some ethical issues

0:06:35.320 --> 0:06:37.360
<v Speaker 1>that you have to look into. Like you can't just

0:06:37.480 --> 0:06:39.400
<v Speaker 1>take a person and then say, all right, we're gonna

0:06:39.440 --> 0:06:42.279
<v Speaker 1>take this one, one person apart and see what makes

0:06:42.279 --> 0:06:45.800
<v Speaker 1>a human body tick. That's there are huge ethical problems

0:06:45.800 --> 0:06:49.960
<v Speaker 1>with that. If you don't recognize that, Uh, why don't

0:06:50.000 --> 0:06:53.480
<v Speaker 1>you go listen to stuff they don't want you to know? Podcast?

0:06:55.640 --> 0:07:03.360
<v Speaker 1>The show for sociopath Love should buy oh snap, if

0:07:03.440 --> 0:07:06.640
<v Speaker 1>Josh and Chuck ever listened to our show that you

0:07:08.600 --> 0:07:14.640
<v Speaker 1>oh no, they're totally scy and they love us so

0:07:15.200 --> 0:07:18.920
<v Speaker 1>at any rate at this stage, UM that the compound

0:07:19.000 --> 0:07:21.480
<v Speaker 1>can go through a lot of these little tweaks that

0:07:21.520 --> 0:07:24.600
<v Speaker 1>we were just talking about. UM, And if all goes well,

0:07:24.840 --> 0:07:29.520
<v Speaker 1>the company developing the drug would submit a Investigational New

0:07:29.600 --> 0:07:32.960
<v Speaker 1>Drug Application or i n D to the f d A,

0:07:33.240 --> 0:07:36.040
<v Speaker 1>which is of course the Food and Drug Administration UM.

0:07:36.280 --> 0:07:39.560
<v Speaker 1>The application will include the chemical and manufacturing data, the

0:07:39.600 --> 0:07:42.440
<v Speaker 1>animal test results featuring a whole bunch of different safety

0:07:42.480 --> 0:07:46.440
<v Speaker 1>margins and whole body effects of the compound UM, and

0:07:46.480 --> 0:07:49.400
<v Speaker 1>then the reasons for proceeding to a human trial, the

0:07:49.440 --> 0:07:54.720
<v Speaker 1>plans for protecting the human volunteers, and the overall testing strategy.

0:07:54.960 --> 0:07:57.880
<v Speaker 1>It's going to be laid out. It's it's not it's

0:07:57.880 --> 0:08:00.480
<v Speaker 1>longer than a book report, y'all right, Because I mean again,

0:08:00.600 --> 0:08:03.720
<v Speaker 1>this is why animals are so important in this phase, right, Because,

0:08:04.560 --> 0:08:07.080
<v Speaker 1>like you were saying, the human body being so complex.

0:08:07.240 --> 0:08:10.320
<v Speaker 1>If you're taking a treatment that's targeting a specific part,

0:08:10.720 --> 0:08:13.280
<v Speaker 1>like let's say it's for a disease that's found in

0:08:13.320 --> 0:08:16.400
<v Speaker 1>the liver, Uh, that does not necessarily mean it won't

0:08:16.440 --> 0:08:19.400
<v Speaker 1>affect other systems in the body. Yeah, the drug is

0:08:19.400 --> 0:08:22.120
<v Speaker 1>not going to magnetically go to the liver and just

0:08:22.200 --> 0:08:24.720
<v Speaker 1>hang out there. It's gonna get into other systems and

0:08:24.840 --> 0:08:28.880
<v Speaker 1>might have unannounced side effects and announced unpredictable side effects.

0:08:28.960 --> 0:08:31.280
<v Speaker 1>And and that's true in animal bodies at least as

0:08:31.320 --> 0:08:33.960
<v Speaker 1>much as it is in humans. And so all of

0:08:33.960 --> 0:08:38.199
<v Speaker 1>this is very sticky. But once once they've been approved

0:08:38.320 --> 0:08:40.640
<v Speaker 1>on their I n D, they can move on to

0:08:40.760 --> 0:08:44.240
<v Speaker 1>clinical trials, which is the official human element in all

0:08:44.280 --> 0:08:48.760
<v Speaker 1>of this. So this occurs in three different phases, phases one, two,

0:08:48.760 --> 0:08:52.280
<v Speaker 1>and three, which take approximately one, two, and three years

0:08:52.320 --> 0:08:55.280
<v Speaker 1>to complete, respectively, although they can take very much longer

0:08:55.320 --> 0:09:00.320
<v Speaker 1>than that depending During Phase one, volunteers are given very

0:09:00.360 --> 0:09:03.719
<v Speaker 1>low doses of the compound, the volunteers might be healthy or,

0:09:03.840 --> 0:09:07.480
<v Speaker 1>in the case of very severe diseases, actual patients, and

0:09:07.600 --> 0:09:11.240
<v Speaker 1>the doses are then gradually increased to test the effects

0:09:11.240 --> 0:09:14.880
<v Speaker 1>and the safety of the drug. About phase two UM.

0:09:14.920 --> 0:09:18.200
<v Speaker 1>About two thirds of drugs tested will proceed onto Phase

0:09:18.240 --> 0:09:22.080
<v Speaker 1>two UM, during which one hundred to three hundred patients

0:09:22.120 --> 0:09:25.520
<v Speaker 1>are given the compound to help determine the most effective

0:09:25.520 --> 0:09:29.479
<v Speaker 1>dose and delivery method and to continue assessing the compounds,

0:09:29.480 --> 0:09:33.000
<v Speaker 1>effects and safety at at these street levels all right,

0:09:33.400 --> 0:09:35.640
<v Speaker 1>um and I don't have an exact number on this one,

0:09:35.720 --> 0:09:38.079
<v Speaker 1>but a lot of drugs drop out of the trial

0:09:38.160 --> 0:09:40.160
<v Speaker 1>phase right here and have to kind of go back

0:09:40.160 --> 0:09:46.040
<v Speaker 1>to the drawing board to be retested and reevaluated, um now.

0:09:46.200 --> 0:09:49.440
<v Speaker 1>To mitigate potential harm, these first two phases are conducted

0:09:49.480 --> 0:09:52.720
<v Speaker 1>with the smallest number of volunteers possible in order to

0:09:52.760 --> 0:09:57.520
<v Speaker 1>gain statistically significant results. But during phase three, the testing

0:09:57.559 --> 0:10:01.360
<v Speaker 1>has opened up to thousands of patients across many different populations,

0:10:01.400 --> 0:10:05.120
<v Speaker 1>which um uh, population is medical jargon for a group

0:10:05.160 --> 0:10:11.160
<v Speaker 1>of people with vaguely common denominators in terms of health

0:10:11.280 --> 0:10:15.079
<v Speaker 1>or age or anything like that. And this is where

0:10:15.160 --> 0:10:18.480
<v Speaker 1>final dosage and safety data are are sessed out, and

0:10:19.160 --> 0:10:21.440
<v Speaker 1>some ten percent of drugs that have made it this

0:10:21.520 --> 0:10:25.160
<v Speaker 1>far will fail to be deemed safe, all right. But

0:10:25.240 --> 0:10:28.079
<v Speaker 1>for the drugs that actually make it through those three phases,

0:10:28.440 --> 0:10:31.920
<v Speaker 1>they just go out into store shells, right PLoP right there.

0:10:32.080 --> 0:10:34.800
<v Speaker 1>Not at all. Now now we are we are we

0:10:34.840 --> 0:10:37.480
<v Speaker 1>are certainly not done yet. All of this pre clinical

0:10:37.520 --> 0:10:40.199
<v Speaker 1>and clinical data is wrapped up into a new drug

0:10:40.240 --> 0:10:44.080
<v Speaker 1>application or n d A in the industry and submitted

0:10:44.120 --> 0:10:46.880
<v Speaker 1>back to the FDA for independent review, which can take

0:10:46.960 --> 0:10:50.360
<v Speaker 1>up to an entire additional year UM during which they

0:10:50.400 --> 0:10:53.760
<v Speaker 1>might ask for more data or corrections, or even stipulate

0:10:53.800 --> 0:10:58.120
<v Speaker 1>a Phase four of testing. And in the end of

0:10:58.120 --> 0:11:01.680
<v Speaker 1>this entire process, only one out of every five thousand

0:11:01.760 --> 0:11:05.000
<v Speaker 1>to ten thousand compounds that entered pre clinical testing to

0:11:05.040 --> 0:11:08.000
<v Speaker 1>begin with will ever be approved by the FDA to

0:11:08.080 --> 0:11:11.520
<v Speaker 1>be marketed to the public um And even after that approval,

0:11:11.760 --> 0:11:14.360
<v Speaker 1>the manufacturer has to check in quarterly with the FDA

0:11:14.440 --> 0:11:17.679
<v Speaker 1>for the next three years, and prescribing physicians have the

0:11:17.720 --> 0:11:22.760
<v Speaker 1>responsibility of reporting adverse reactions and and the company itself

0:11:22.960 --> 0:11:25.719
<v Speaker 1>might choose to continue clinical trials to assess like long

0:11:25.840 --> 0:11:29.319
<v Speaker 1>term effects and continue tweaking dosage recommendations and safety and

0:11:29.400 --> 0:11:32.840
<v Speaker 1>stuff like that. Or might have side effects that just

0:11:32.960 --> 0:11:37.360
<v Speaker 1>happened to be really useful for curing other problems. Ah, Yes,

0:11:37.679 --> 0:11:40.920
<v Speaker 1>like a like a medicine that might be used for

0:11:41.679 --> 0:11:47.280
<v Speaker 1>cardiovascular purposes that perhaps addresses a completely different issue for

0:11:47.640 --> 0:11:51.160
<v Speaker 1>people who are looking for a particular solution to a

0:11:51.200 --> 0:11:53.839
<v Speaker 1>particular problem. I think I know what you're talking about,

0:11:53.840 --> 0:11:56.079
<v Speaker 1>But biagraa I believe is that would be the one

0:11:56.080 --> 0:11:59.880
<v Speaker 1>I was specifically dancing around. So now that we've covered

0:12:00.720 --> 0:12:04.520
<v Speaker 1>what about some of the issues that we've got this

0:12:04.520 --> 0:12:12.680
<v Speaker 1>this incredibly large, encompassing process that is meant to make

0:12:12.760 --> 0:12:15.640
<v Speaker 1>sure that whatever comes out at the end of it

0:12:15.679 --> 0:12:18.320
<v Speaker 1>is the most beneficial right, that that is going to

0:12:18.600 --> 0:12:22.280
<v Speaker 1>not cause harm ideally and will actually be efficacious for

0:12:22.360 --> 0:12:25.199
<v Speaker 1>what it's intended to do, or the at least the

0:12:25.600 --> 0:12:29.000
<v Speaker 1>horror outweighs or the benefits outweigh the horror exactly. So

0:12:29.000 --> 0:12:32.280
<v Speaker 1>So what what are some of the problems with this process?

0:12:32.280 --> 0:12:37.559
<v Speaker 1>I mean, clearly, we want something that's very uh you know, meticulous,

0:12:37.600 --> 0:12:40.280
<v Speaker 1>so that we don't cause large amount of harm, But

0:12:40.320 --> 0:12:43.440
<v Speaker 1>what are some of the drawbacks here? Well, for one, thing,

0:12:43.800 --> 0:12:46.559
<v Speaker 1>sounds like it takes a really long time. Yeah, I

0:12:46.600 --> 0:12:49.640
<v Speaker 1>think eight to twelve years is the average. So meanwhile,

0:12:49.679 --> 0:12:53.920
<v Speaker 1>you have people suffering from whatever the drug was intended

0:12:53.960 --> 0:12:56.640
<v Speaker 1>to address. I mean, assuming that it's a good drug

0:12:56.720 --> 0:12:59.000
<v Speaker 1>that does work right, yeah, yeah, and it can be

0:12:59.080 --> 0:13:03.760
<v Speaker 1>sped up in certain circumstances like for example, during the

0:13:03.559 --> 0:13:07.440
<v Speaker 1>the the aid's outbreak in the nineteen eighties. Uh, some

0:13:07.440 --> 0:13:10.400
<v Speaker 1>some drugs were pushed through very very quickly, and and

0:13:10.440 --> 0:13:13.240
<v Speaker 1>that is a thing that can happen in that kind

0:13:13.320 --> 0:13:17.480
<v Speaker 1>of case an extreme circumstances. But it also sounds to

0:13:17.520 --> 0:13:19.960
<v Speaker 1>me like this process might might have a bit of

0:13:20.000 --> 0:13:24.080
<v Speaker 1>a price tag to it. Yep. According to the Pharmaceutical

0:13:24.120 --> 0:13:27.840
<v Speaker 1>Research and Manufacturers of America, as of the year two thousand,

0:13:28.200 --> 0:13:31.760
<v Speaker 1>it costs more than five hundred million dollars to bring

0:13:31.840 --> 0:13:35.560
<v Speaker 1>the average drug to market. And that was fourteen years ago,

0:13:35.640 --> 0:13:38.960
<v Speaker 1>so as of today, it's probably a low ball. Um.

0:13:39.040 --> 0:13:42.400
<v Speaker 1>Of course, not all of that is um specifically wrapped

0:13:42.480 --> 0:13:47.120
<v Speaker 1>up in clinical trial, which is kind of the part

0:13:47.160 --> 0:13:50.040
<v Speaker 1>that we're dancing around with the entire topic of this episode,

0:13:50.360 --> 0:13:53.360
<v Speaker 1>and wherein organs on chips are going to come back

0:13:53.400 --> 0:13:57.840
<v Speaker 1>to us that that might take umasily um two million

0:13:57.880 --> 0:14:00.280
<v Speaker 1>dollars at the kind of low end of estimate. Now,

0:14:00.360 --> 0:14:03.319
<v Speaker 1>keep that you might wonder about, you know, the pharmaceutical industry.

0:14:03.320 --> 0:14:06.840
<v Speaker 1>Everyone talks about being a multibillion dollar industry, but as

0:14:06.880 --> 0:14:11.079
<v Speaker 1>we've set up this this process, it requires you to

0:14:11.200 --> 0:14:16.040
<v Speaker 1>have a huge amount of of cash. Just yeah, you

0:14:16.080 --> 0:14:18.640
<v Speaker 1>can't you can't just jump into the market willy nilly,

0:14:18.840 --> 0:14:22.080
<v Speaker 1>simply because you do have to meet these very strict

0:14:22.120 --> 0:14:25.880
<v Speaker 1>standards in order to move forward. Another problem I would

0:14:25.880 --> 0:14:29.280
<v Speaker 1>see with this whole process is the concept of animal testing,

0:14:29.920 --> 0:14:32.280
<v Speaker 1>which can be a problem for multiple reasons. I mean,

0:14:32.360 --> 0:14:35.440
<v Speaker 1>number one, there is just the the ethical concern. I

0:14:35.440 --> 0:14:37.840
<v Speaker 1>mean that it's a hard question to way that. Like,

0:14:37.960 --> 0:14:40.880
<v Speaker 1>you know, obviously we want to be able to create

0:14:40.920 --> 0:14:43.960
<v Speaker 1>drugs that can save human lives, but you know, how

0:14:43.960 --> 0:14:45.920
<v Speaker 1>many animals do you have to kill to do that,

0:14:46.040 --> 0:14:50.040
<v Speaker 1>and what's what's the scale there? But beyond that, there

0:14:50.120 --> 0:14:53.920
<v Speaker 1>is the question of how much can we necessarily learn

0:14:54.200 --> 0:14:57.960
<v Speaker 1>from animal testing. Obviously we can learn something, so it's

0:14:58.000 --> 0:15:01.200
<v Speaker 1>not saying that that's worthless course, but you know, at

0:15:01.200 --> 0:15:04.160
<v Speaker 1>a certain point when you're when you move from animal

0:15:04.160 --> 0:15:07.800
<v Speaker 1>testing into human testing and you realize that that things

0:15:07.840 --> 0:15:10.560
<v Speaker 1>that you had previously assumed based on your animal tests

0:15:10.560 --> 0:15:13.840
<v Speaker 1>are completely incorrect in a human it's it's heartbreaking for

0:15:13.880 --> 0:15:16.440
<v Speaker 1>everyone involved. Yeah, there's it's a waste of time and

0:15:16.520 --> 0:15:18.920
<v Speaker 1>money in life, and it's also an increase in risk. Yeah,

0:15:19.080 --> 0:15:22.400
<v Speaker 1>there's there's a chance that something that had no toxicity

0:15:22.560 --> 0:15:26.240
<v Speaker 1>in your animal models may be toxic in humans. Um,

0:15:26.240 --> 0:15:28.720
<v Speaker 1>it's or vice versa. I mean, there are things that

0:15:28.880 --> 0:15:31.680
<v Speaker 1>we humans can consume that are fine, and if an

0:15:31.680 --> 0:15:34.880
<v Speaker 1>animal consumed it, it might not be able to survive

0:15:35.000 --> 0:15:37.280
<v Speaker 1>or it could end up suffering at least some form

0:15:37.280 --> 0:15:40.520
<v Speaker 1>of poisoning. So it's uh, the animal models are not

0:15:40.520 --> 0:15:43.800
<v Speaker 1>always predictive for what will happen when you transfer that

0:15:43.920 --> 0:15:46.120
<v Speaker 1>same sort of treatment over to a human. Also, keep

0:15:46.120 --> 0:15:49.960
<v Speaker 1>in mind we're talking specifically about testing drugs, but other

0:15:50.000 --> 0:15:53.560
<v Speaker 1>types of chemicals are also tested on animals because of

0:15:53.680 --> 0:15:58.800
<v Speaker 1>similar reasons, things like cosmetics or just chemicals that humans

0:15:58.800 --> 0:16:01.560
<v Speaker 1>would come into contact with than it. And so anyone

0:16:01.600 --> 0:16:04.880
<v Speaker 1>who's making said chemical for some product has to be

0:16:04.960 --> 0:16:09.320
<v Speaker 1>able to demonstrate what are the parameter for safety, parameters

0:16:09.360 --> 0:16:13.200
<v Speaker 1>for its use. So all of that requires animal testing,

0:16:13.440 --> 0:16:17.560
<v Speaker 1>and obviously, uh, you know, depending upon your personal feelings

0:16:17.600 --> 0:16:20.840
<v Speaker 1>towards animal testing, this may be very disturbing to you.

0:16:21.120 --> 0:16:22.880
<v Speaker 1>Oh sure, sure, I mean, you know, I think that

0:16:22.960 --> 0:16:26.720
<v Speaker 1>we can all agree that. Um, if you're testing cancer treatments,

0:16:26.960 --> 0:16:30.920
<v Speaker 1>then you know, I'm really sorry, Fluffy, but it's for

0:16:30.960 --> 0:16:32.640
<v Speaker 1>the best. It's for the best for all of us.

0:16:33.000 --> 0:16:36.680
<v Speaker 1>But if you're testing mascara, then I get that upsets

0:16:36.680 --> 0:16:39.720
<v Speaker 1>people a little bit more. Yes, clearly, So one of

0:16:39.760 --> 0:16:44.960
<v Speaker 1>the potential solutions for this this ethical issue is this

0:16:45.040 --> 0:16:48.760
<v Speaker 1>concept of an organ on a chip, and really this

0:16:48.840 --> 0:16:53.600
<v Speaker 1>would mostly concern those pre clinical phases. Lauren talked about

0:16:53.640 --> 0:16:58.480
<v Speaker 1>the ones that are animal testing in particular. Potentially this

0:16:58.560 --> 0:17:02.880
<v Speaker 1>particular type of technolo oology could help reduce or even

0:17:02.920 --> 0:17:06.040
<v Speaker 1>eliminate the need for animal testing if it proves to

0:17:06.160 --> 0:17:10.240
<v Speaker 1>be an effective enough platform. Okay, so what is an

0:17:10.320 --> 0:17:13.840
<v Speaker 1>organ on a chip? All right? So it looks kind

0:17:13.880 --> 0:17:16.399
<v Speaker 1>of like a little plastic chip about the size of

0:17:16.440 --> 0:17:20.399
<v Speaker 1>a USB flash drive, little thumb drive. Um, not a

0:17:20.520 --> 0:17:21.920
<v Speaker 1>not a full drive, but you know, just one of

0:17:21.960 --> 0:17:23.479
<v Speaker 1>those little things you up on your key chain. It's

0:17:23.520 --> 0:17:26.160
<v Speaker 1>about that same size. So it's a it's got these

0:17:26.200 --> 0:17:31.399
<v Speaker 1>hollow micro fluidic channels that are lined with actual human cells,

0:17:31.480 --> 0:17:35.159
<v Speaker 1>like living human tissue exactly. I mean, it's obviously not

0:17:35.160 --> 0:17:39.480
<v Speaker 1>connected to a human but yeah, the actual the actual

0:17:39.560 --> 0:17:43.280
<v Speaker 1>cells are viable cells. They aren't just you know, just

0:17:43.280 --> 0:17:46.920
<v Speaker 1>just desiccated cells that actually do live. And the chip

0:17:47.040 --> 0:17:51.160
<v Speaker 1>replicates the functions of a particular organ, and the organ

0:17:51.240 --> 0:17:54.720
<v Speaker 1>is all dependent upon what you've lined the these micro

0:17:54.840 --> 0:17:58.439
<v Speaker 1>fluidic channels with. So, for example, a lung on a

0:17:58.560 --> 0:18:01.399
<v Speaker 1>chip would include a membrane that on one side is

0:18:01.440 --> 0:18:03.760
<v Speaker 1>lined with lung cells, and on the other side of

0:18:03.760 --> 0:18:06.560
<v Speaker 1>the membrane, the flip side, you would have human blood

0:18:06.560 --> 0:18:11.480
<v Speaker 1>cells lining it, and you could have air essentially circulating

0:18:11.520 --> 0:18:15.560
<v Speaker 1>across the lung cells and blood or some sort of

0:18:15.600 --> 0:18:19.920
<v Speaker 1>blood simulated fluid moving across the other cells on the

0:18:19.960 --> 0:18:22.520
<v Speaker 1>other side of the membrane, and the membrane itself can

0:18:22.560 --> 0:18:28.639
<v Speaker 1>actually expand and contract, thus mimicking the physiological function of

0:18:28.680 --> 0:18:33.200
<v Speaker 1>a lung. Okay, but we already test drugs, I believe

0:18:33.240 --> 0:18:37.280
<v Speaker 1>in the pre clinical phase on like cultures like lab

0:18:37.320 --> 0:18:40.480
<v Speaker 1>dishes full of cells, don't we yes, So what kind

0:18:40.520 --> 0:18:43.000
<v Speaker 1>of difference would the organ on a chip make? Well

0:18:43.040 --> 0:18:45.800
<v Speaker 1>a culture of living cells. Obviously it's really important to

0:18:45.920 --> 0:18:47.760
<v Speaker 1>use that and to see what the effects are. But

0:18:47.800 --> 0:18:53.240
<v Speaker 1>the culture of cells doesn't have the physiological function of

0:18:53.280 --> 0:18:55.520
<v Speaker 1>the organ it comes from, right, It's just a collection

0:18:55.520 --> 0:18:58.360
<v Speaker 1>of living cells that represent that tissue, but it's not

0:18:58.880 --> 0:19:02.240
<v Speaker 1>performing functions of an organ. Okay, so we don't get

0:19:02.240 --> 0:19:05.000
<v Speaker 1>to see them in action. Yeah. Yeah. It's kind of

0:19:05.040 --> 0:19:07.760
<v Speaker 1>like if you were to take a gear out of

0:19:07.800 --> 0:19:10.720
<v Speaker 1>a clock and just look at the gear. It's not

0:19:11.040 --> 0:19:14.480
<v Speaker 1>doing anything. Uh yeah, And that the metabolic processes that

0:19:14.520 --> 0:19:17.359
<v Speaker 1>any of our organs go through are going to change

0:19:17.800 --> 0:19:20.800
<v Speaker 1>physically change the way that the cells are functioning. So

0:19:20.840 --> 0:19:23.600
<v Speaker 1>this is a very important piece of the puzzle. So

0:19:23.800 --> 0:19:26.879
<v Speaker 1>depending upon what organ you're talking about, the chip is

0:19:26.880 --> 0:19:30.359
<v Speaker 1>going to perform in a specific way. Right. It's not

0:19:30.880 --> 0:19:32.800
<v Speaker 1>like a lung on a chip is going to behave

0:19:32.840 --> 0:19:34.720
<v Speaker 1>the same way as a bone marrow on a chip.

0:19:35.200 --> 0:19:38.040
<v Speaker 1>But not unless you've got something very strange going on

0:19:38.080 --> 0:19:40.320
<v Speaker 1>with your bone marrow. Yeah, that then you have some

0:19:40.400 --> 0:19:43.159
<v Speaker 1>other issues. So if we go to that lung on

0:19:43.200 --> 0:19:45.879
<v Speaker 1>a chip example, the chip has this air flow across

0:19:45.920 --> 0:19:48.520
<v Speaker 1>the lung cells and the blood like fluid across the

0:19:48.560 --> 0:19:51.760
<v Speaker 1>other cells on the other side, and this is what

0:19:51.880 --> 0:19:55.400
<v Speaker 1>allows it to simulate the performance of a lung. UH.

0:19:55.400 --> 0:19:57.879
<v Speaker 1>These particular types of chips are being developed by a

0:19:57.960 --> 0:20:01.679
<v Speaker 1>couple of different groups. The one that I specifically was

0:20:01.760 --> 0:20:05.000
<v Speaker 1>really interested in was the VS Institute, which is a

0:20:05.040 --> 0:20:08.879
<v Speaker 1>biological research institute that's part of Harvard University. UH. They've

0:20:08.920 --> 0:20:14.360
<v Speaker 1>created ten different organs on a chip models, including liver, gut, kidney,

0:20:14.440 --> 0:20:18.960
<v Speaker 1>and bone marrow UH and UH they're looking to partner

0:20:19.000 --> 0:20:23.600
<v Speaker 1>with pharmaceutical companies. UH with biologists with chemists to test

0:20:23.680 --> 0:20:25.920
<v Speaker 1>these out to make sure that they are in fact

0:20:26.520 --> 0:20:31.280
<v Speaker 1>good analogs for actual human organs. Um And in late

0:20:31.359 --> 0:20:35.760
<v Speaker 1>July of two thousand fourteen, the department that was specifically

0:20:35.800 --> 0:20:39.240
<v Speaker 1>working on organs on a chip within the VS Institute

0:20:39.880 --> 0:20:43.399
<v Speaker 1>has spun off a new private company in partnership with

0:20:43.440 --> 0:20:47.439
<v Speaker 1>a startup called Emulate Incorporated, which has a worldwide license

0:20:47.520 --> 0:20:51.439
<v Speaker 1>to commercialize this technology platform and try and move it

0:20:51.480 --> 0:20:54.400
<v Speaker 1>forward to the next phase, which would involve using these

0:20:54.400 --> 0:20:57.720
<v Speaker 1>and very very uh controlled tests too. You know, you

0:20:57.840 --> 0:21:01.400
<v Speaker 1>probably start actually with stuff that's already been thoroughly tested

0:21:01.600 --> 0:21:04.600
<v Speaker 1>to make sure that the organ on a chip behaves

0:21:04.600 --> 0:21:06.960
<v Speaker 1>in the way you would in a predictable manner exactly,

0:21:07.160 --> 0:21:10.760
<v Speaker 1>so that you can prove that the technology works. Um.

0:21:10.800 --> 0:21:14.040
<v Speaker 1>There's another company called Nordis in O R T I

0:21:14.240 --> 0:21:16.720
<v Speaker 1>S that's also working on organ on a chip platforms.

0:21:16.720 --> 0:21:18.720
<v Speaker 1>They have a goal of launching a product in two

0:21:18.760 --> 0:21:22.399
<v Speaker 1>thousand and fifteen. They the company itself launched back in

0:21:22.440 --> 0:21:24.960
<v Speaker 1>two thousand and twelve. They spun off from a research

0:21:25.000 --> 0:21:27.760
<v Speaker 1>group at the University of Washington UH. They developed a

0:21:27.840 --> 0:21:32.200
<v Speaker 1>chip that actually mimics the blood brain barrier, which is

0:21:32.240 --> 0:21:34.760
<v Speaker 1>pretty awesome. That's one of those things in medicine that

0:21:35.200 --> 0:21:37.760
<v Speaker 1>fascinates and confuses me every time I hear about it.

0:21:37.760 --> 0:21:40.960
<v Speaker 1>It's one of those, uh difficult issues, is how do

0:21:41.000 --> 0:21:44.119
<v Speaker 1>you get things that either do not breach the blood

0:21:44.119 --> 0:21:47.280
<v Speaker 1>brain barrier or do breach the blood brain barrier. So

0:21:48.200 --> 0:21:51.200
<v Speaker 1>with the startup, I think we're gonna see some partnerships

0:21:51.240 --> 0:21:55.680
<v Speaker 1>between Emulat Incorporated and other companies to really test these

0:21:55.680 --> 0:21:59.159
<v Speaker 1>out and check to make sure that these actually do

0:21:59.240 --> 0:22:03.160
<v Speaker 1>work as an analog um and it's interesting. They've even

0:22:03.240 --> 0:22:06.400
<v Speaker 1>come up with a a version where they can hook

0:22:06.520 --> 0:22:09.679
<v Speaker 1>up the different organs on a chip together in a

0:22:09.760 --> 0:22:13.879
<v Speaker 1>system to simulate an entire human body. So essentially you

0:22:13.920 --> 0:22:18.120
<v Speaker 1>have all these different chips operating as the different organs, uh,

0:22:18.119 --> 0:22:22.400
<v Speaker 1>And that way you can check whole body effects. Yeah.

0:22:22.440 --> 0:22:24.280
<v Speaker 1>So if you again, if you have that drug to

0:22:24.520 --> 0:22:26.840
<v Speaker 1>treat the liver and you want to make sure it's

0:22:26.840 --> 0:22:29.080
<v Speaker 1>not going to put too much stress on some other organ,

0:22:29.320 --> 0:22:32.600
<v Speaker 1>you could introduce it and this will behave as if

0:22:32.640 --> 0:22:36.560
<v Speaker 1>it were a human in miniature in a way. I mean,

0:22:36.600 --> 0:22:39.680
<v Speaker 1>we're talking about teeny tiny elements that are replicating the

0:22:39.720 --> 0:22:44.480
<v Speaker 1>basic functions of the organs that they represent. Yeah, it's

0:22:44.520 --> 0:22:47.600
<v Speaker 1>it's really really mind blowing to think that such a

0:22:47.640 --> 0:22:53.000
<v Speaker 1>tiny sample of cells could be representative of an entire

0:22:53.160 --> 0:22:56.719
<v Speaker 1>organ and its functions. But it is. That's that's at

0:22:56.800 --> 0:23:00.840
<v Speaker 1>least the pitch will find out. Yeah, and you know what,

0:23:00.960 --> 0:23:04.320
<v Speaker 1>while we're we mentioned cost earlier, and right now, this

0:23:04.400 --> 0:23:08.240
<v Speaker 1>sounds like it would not be cheaper. Probably then the

0:23:08.280 --> 0:23:11.560
<v Speaker 1>goal is that by using just very tiny amounts of

0:23:11.680 --> 0:23:16.080
<v Speaker 1>cells and having a streamlined production method, you could actually

0:23:16.080 --> 0:23:18.280
<v Speaker 1>produce a whole bunch of these with just a tiny

0:23:18.320 --> 0:23:22.160
<v Speaker 1>amount of actual cultured material. Right, So you wouldn't have

0:23:22.280 --> 0:23:25.840
<v Speaker 1>to have a whole lot of of of raw material

0:23:25.920 --> 0:23:29.280
<v Speaker 1>to start with. We're talking about just tiny amounts of cells.

0:23:29.960 --> 0:23:32.600
<v Speaker 1>Once we can mass manufacture livers on a chip, then

0:23:33.280 --> 0:23:35.920
<v Speaker 1>just livers for days, right, and then you just think,

0:23:35.960 --> 0:23:38.399
<v Speaker 1>you know, you don't have to worry about procuring animals.

0:23:38.480 --> 0:23:41.200
<v Speaker 1>You don't have to worry about all the other issues

0:23:41.240 --> 0:23:43.840
<v Speaker 1>that would come along with that. So this would at least,

0:23:43.840 --> 0:23:47.520
<v Speaker 1>in theory, like I said, reduce or perhaps even eliminate

0:23:47.520 --> 0:23:50.840
<v Speaker 1>animal testing. If in fact they worked as perfect analogs

0:23:50.840 --> 0:23:53.399
<v Speaker 1>for humans, then you could say, well, let's test it

0:23:53.440 --> 0:23:55.640
<v Speaker 1>on this and if it works here, then we can

0:23:55.680 --> 0:23:58.960
<v Speaker 1>start looking at this replacing the animal testing portion of

0:23:59.000 --> 0:24:02.080
<v Speaker 1>pre clinical trial. Yeah, you know, even hopefully. We've talked

0:24:02.080 --> 0:24:04.960
<v Speaker 1>a lot about the dangers to animals in these trials,

0:24:04.960 --> 0:24:07.320
<v Speaker 1>but the dangers to the human volunteers, especially at the

0:24:07.400 --> 0:24:10.320
<v Speaker 1>very start, short of the clinical phase of trials, is

0:24:10.359 --> 0:24:13.600
<v Speaker 1>also huge. Uh So absolutely, Yeah, you might be able

0:24:13.640 --> 0:24:16.080
<v Speaker 1>to find out that something that you thought was going

0:24:16.119 --> 0:24:20.160
<v Speaker 1>to be perfectly acceptable might be toxic, and in which

0:24:20.200 --> 0:24:22.119
<v Speaker 1>case you would know immediately like, well, this is a

0:24:22.200 --> 0:24:24.000
<v Speaker 1>this is a failure. We're going to have to completely

0:24:24.000 --> 0:24:27.439
<v Speaker 1>rethink this. Uh and then not put any actual person

0:24:27.600 --> 0:24:30.280
<v Speaker 1>in danger. You've just all you've done is destroyed some

0:24:30.359 --> 0:24:34.719
<v Speaker 1>chips that can easily be replaced, whereas people irreplaceable. Okay,

0:24:34.760 --> 0:24:37.040
<v Speaker 1>so this sounds like crazy science fiction, but it is

0:24:37.080 --> 0:24:40.000
<v Speaker 1>happening right now in various places around the world. What

0:24:40.160 --> 0:24:43.360
<v Speaker 1>is the crazier science fiction version of this? Let's let's

0:24:43.359 --> 0:24:46.439
<v Speaker 1>blow this out into the future. My favorite version of this.

0:24:46.560 --> 0:24:49.200
<v Speaker 1>I mean, it's beyond the whole idea of of using

0:24:49.200 --> 0:24:51.960
<v Speaker 1>this for drugs or or cosmetics or chemicals. I would

0:24:52.000 --> 0:24:55.639
<v Speaker 1>love a world where we can test chemicals and cosmetics

0:24:55.640 --> 0:24:58.440
<v Speaker 1>on this kind of platform and never have to worry

0:24:58.480 --> 0:25:02.160
<v Speaker 1>about subjecting animal as to that. That would be fantastic.

0:25:02.400 --> 0:25:06.080
<v Speaker 1>But beyond that, imagine a world where you go in

0:25:06.480 --> 0:25:09.600
<v Speaker 1>to let's say that you you have a serious disease

0:25:10.080 --> 0:25:13.360
<v Speaker 1>and you need to have it have treatment for that disease.

0:25:13.600 --> 0:25:15.600
<v Speaker 1>Let's say you go in and you have you get

0:25:15.680 --> 0:25:18.560
<v Speaker 1>some the doctors get some samples of your various the

0:25:18.600 --> 0:25:23.840
<v Speaker 1>cells and your various organs and create a specific body

0:25:23.880 --> 0:25:27.800
<v Speaker 1>on a chip analog to you, specific to you, like

0:25:27.920 --> 0:25:32.760
<v Speaker 1>your body chemistry, and then test out the various potential

0:25:32.760 --> 0:25:36.760
<v Speaker 1>treatments on that analog before giving it to you, and

0:25:36.800 --> 0:25:40.760
<v Speaker 1>then they know which ones are potentially the most efficacious,

0:25:40.840 --> 0:25:43.800
<v Speaker 1>the ones that are most guaranteed to get you better.

0:25:44.119 --> 0:25:48.760
<v Speaker 1>We're talking about customized healthcare to the patients exactly the

0:25:48.800 --> 0:25:50.480
<v Speaker 1>same same sort of level that we talk about when

0:25:50.480 --> 0:25:55.359
<v Speaker 1>we talk about nanotechnology being used to diagnose and treat patients,

0:25:55.400 --> 0:26:00.720
<v Speaker 1>so that the care is so specifically applied that uh,

0:26:00.760 --> 0:26:04.240
<v Speaker 1>it reduces side effects as much as is possible. Yeah,

0:26:04.320 --> 0:26:07.040
<v Speaker 1>that would be It would be amazing. Like I have

0:26:07.160 --> 0:26:13.679
<v Speaker 1>so many friends who have had various incredibly difficult treatments

0:26:13.720 --> 0:26:17.560
<v Speaker 1>for various ailments. Throughout their lives, and to think of

0:26:17.640 --> 0:26:22.320
<v Speaker 1>something like this potentially being able to reduce that level

0:26:22.359 --> 0:26:24.919
<v Speaker 1>of stress and anxiety of patient feels, as well as

0:26:24.960 --> 0:26:28.200
<v Speaker 1>just that the hardship of going through treatment, it would

0:26:28.200 --> 0:26:31.399
<v Speaker 1>be amazing. And even on even on really basic medication levels,

0:26:31.840 --> 0:26:35.000
<v Speaker 1>you know, people are all so different, and even with

0:26:35.040 --> 0:26:38.720
<v Speaker 1>all of those hundreds or or thousands of volunteers that

0:26:38.760 --> 0:26:41.400
<v Speaker 1>they get to test out any given drug, you have

0:26:41.440 --> 0:26:45.320
<v Speaker 1>no idea how it's going to interact with your specific physiology.

0:26:45.440 --> 0:26:49.000
<v Speaker 1>That's true, and so that's that that really is a

0:26:49.040 --> 0:26:52.679
<v Speaker 1>beautiful that's the worldless statistics. Right, statistics tells you what

0:26:52.800 --> 0:26:56.480
<v Speaker 1>the likelihood is that you will have any given reaction

0:26:56.560 --> 0:27:01.080
<v Speaker 1>to any given treatment. But statistics, that's just that's a percentage.

0:27:01.200 --> 0:27:04.560
<v Speaker 1>When you get down to an individual basis, things can

0:27:04.680 --> 0:27:09.000
<v Speaker 1>go sometimes outside those parameters. It can happen if there's

0:27:09.040 --> 0:27:12.040
<v Speaker 1>a if there's a statistical percentage that it's possible it

0:27:12.119 --> 0:27:14.960
<v Speaker 1>will happen at least with some people. So this is

0:27:15.000 --> 0:27:18.280
<v Speaker 1>a way of being able to spot those outliers early.

0:27:18.440 --> 0:27:21.720
<v Speaker 1>Or maybe you notice that perhaps because of your body chemistry,

0:27:21.920 --> 0:27:25.880
<v Speaker 1>you might have an allergic reaction to something that for

0:27:26.080 --> 0:27:28.800
<v Speaker 1>most people in your condition would be a completely valid

0:27:28.800 --> 0:27:32.040
<v Speaker 1>treatment that would be good to know before getting it done.

0:27:32.880 --> 0:27:37.960
<v Speaker 1>So uh so really promising work, fascinating stuff, and uh

0:27:38.040 --> 0:27:40.680
<v Speaker 1>there are a lot of different articles about it. Most

0:27:40.680 --> 0:27:42.920
<v Speaker 1>of them are just kind of relate back to the

0:27:43.000 --> 0:27:46.239
<v Speaker 1>individual websites of the companies that are are doing this

0:27:46.400 --> 0:27:48.960
<v Speaker 1>or the division of of Vise institute that's doing this.

0:27:49.400 --> 0:27:52.359
<v Speaker 1>But it's I'm really curious to see how this goes along.

0:27:52.400 --> 0:27:56.439
<v Speaker 1>I'm hopeful that it will pan out and be a

0:27:56.560 --> 0:28:01.400
<v Speaker 1>viable testing procedure for for pharmaceutical chemicals, cosmetics, that kind

0:28:01.400 --> 0:28:03.640
<v Speaker 1>of thing down the line, because if it is, then

0:28:03.720 --> 0:28:06.720
<v Speaker 1>that's gonna be good news for everyone involved. And uh,

0:28:06.880 --> 0:28:08.639
<v Speaker 1>maybe it will mean that we'll be able to have

0:28:08.720 --> 0:28:12.240
<v Speaker 1>more effective drugs on the market, maybe a little faster,

0:28:12.400 --> 0:28:15.000
<v Speaker 1>not necessary. It won't necessarily speed up everything because clearly

0:28:15.040 --> 0:28:17.840
<v Speaker 1>there will still be the need for full clinical trials.

0:28:17.840 --> 0:28:20.440
<v Speaker 1>It's not like this is going to replace the entire process,

0:28:21.119 --> 0:28:23.400
<v Speaker 1>but it might be able to fix part of it,

0:28:23.720 --> 0:28:27.479
<v Speaker 1>or at least streamline part of it. So, uh, anything

0:28:27.520 --> 0:28:28.960
<v Speaker 1>else you guys want to say about organs on a

0:28:29.000 --> 0:28:31.600
<v Speaker 1>chip besides the fact that, uh, we're still disappointed. It's

0:28:31.600 --> 0:28:34.600
<v Speaker 1>not snack food. I'm not disappointed anymore. Now you're not, no,

0:28:34.720 --> 0:28:37.520
<v Speaker 1>because now now you've got this hopeful view of the future. Right, yeah,

0:28:37.960 --> 0:28:40.600
<v Speaker 1>I'm not disappointed by I'm still a little bit hungry. Okay,

0:28:40.680 --> 0:28:43.200
<v Speaker 1>Well that's probably a good queue for us to wrap

0:28:43.240 --> 0:28:46.080
<v Speaker 1>things up then, so we're going to end up concluding.

0:28:46.080 --> 0:28:48.240
<v Speaker 1>But you guys, if you have any suggestions for future

0:28:48.240 --> 0:28:51.800
<v Speaker 1>topics of forward thinking, maybe there's some specific element of

0:28:51.880 --> 0:28:55.080
<v Speaker 1>science or technology, or you're just wondering, like what's it

0:28:55.080 --> 0:28:57.440
<v Speaker 1>gonna be like, Like what's my commute going to be

0:28:57.480 --> 0:28:59.920
<v Speaker 1>like in twenty years? Is it going to be easier

0:29:00.120 --> 0:29:02.320
<v Speaker 1>or will there be way too many people everywhere and

0:29:02.360 --> 0:29:04.760
<v Speaker 1>I'll never get to where I need to go? If

0:29:04.800 --> 0:29:07.360
<v Speaker 1>you live in Atlanta, it's going to be the second one.

0:29:07.680 --> 0:29:09.760
<v Speaker 1>Let us know what you want us to talk about.

0:29:09.920 --> 0:29:12.800
<v Speaker 1>Drop us a line on Facebook, Twitter, or Google Plus.

0:29:12.800 --> 0:29:15.360
<v Speaker 1>Our handle at all three is f W Thinking and

0:29:15.400 --> 0:29:22.680
<v Speaker 1>we will talk to you again really soon. For more

0:29:22.680 --> 0:29:25.280
<v Speaker 1>on this topic in the future of technology, I visit

0:29:25.320 --> 0:29:38.480
<v Speaker 1>forward thinking dot Com, brought to you by Toyota. Let's

0:29:38.520 --> 0:29:39.200
<v Speaker 1>go places